Book chapters

Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 481-500

This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by examining how various pathogens cause a variety of central nervous system (CNS) dysfunctions and the mechanisms of these changes.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 147-164

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing the most recent scientific advances that have improved diagnostic abilities and showcasing experimental studies of gene therapy and conventional pharmacological treatments to lead to effective treatment of these hereditary disorders.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 233-251

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by highlighting amyotrophic lateral sclerosis (ALS), a neurodegenerative disease of the motor system characterized by focal and then generalized weakness leading to paralysis and death from respiratory failure.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 275-292

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on the clinical features, ethics, and neurobiology of HD and the exciting approaches being employed today to advance understanding of underlying mechanisms in an effort to develop therapies that would delay the onset and slow progression of this disease.
Elsevier,

Current Directions in Water Scarcity Research, Volume 4, 2022, Pages 1-11

The emergence of global environmental challenges like climate change and its many regional manifestations has presented new threats to Indigenous land and water resources the world over. Despite these new challenges, which compound the impacts of colonial legacies on traditional stewardship practices and governance frameworks, Indigenous Peoples continue to demonstrate formidable resilience and an unwavering “responsibility-based” approach to water and drought management.
Elsevier,

Pandemic Risk, Response, and Resilience, COVID-19 Responses in Cities Around the World, 2022, Pages 3-12

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by providing an understanding of understand the inequalities between countries and shifting modality in risk governance. The case studies of COVID-19 pandemic impacts, governance, and consequences have been analyzed from various perspectives at the local, national, and regional levels.
Elsevier,

Artificial Intelligence in Urban Planning and Design, Technologies, Implementation, and Impacts, 2022, Pages 121-138

This chapter advances the UN SDG Goal 3: Good Health by providing an overview of research on the use of image data of the built environment to analyze impacts on human health and explaining the challenges that need to be addressed to realize a new data-driven era of urban analysis and planning.
Elsevier,

Essential Human Virology (Second Edition), 2023, Pages 231-253

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the clinical aspects, epidemiology, and molecular virology of the major hepatitis viruses.
Elsevier,

Encyclopedia of Inland Waters (Second Edition), Elsevier, 2022, Pages 511-519, ISBN: 9780128220412

This chapter advances the UN SDG goals 5 and 11 by discussing the gender disparity concerning publication and impact of papers focussed on aquatic resources and fisheries.
Elsevier,

Translational Autoimmunity, Autoimmune Diseases in Different Organs, Volume 4 in Translational Immunology, 2022, Pages 309-331

This chapter aligns with the SDG goal 3 of good health and wellbeing by examining current efforts to treat patients who do not adequately respond to standard immunosuppressive treatments as well as to find novel noninvasive biomarkers that can reliably substitute liver histology in assessing liver fibrosis and in predicting hard long-term outcomes.

Pages